Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Catheter Ablation Using a Novel Navigation and Imaging System

NCT: NCT06895187 · NOT_YET_RECRUITING

NCT IDNCT06895187
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2027-09-01

Brief Summary

The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).

Frequently Asked Questions

What is Catheter Ablation Using a Novel Navigation and Imaging System?

Catheter Ablation Using a Novel Navigation and Imaging System is a clinical trial registered under NCT06895187. Current status: NOT_YET_RECRUITING.

What is the status of NCT06895187?

The current status of NCT06895187 (Catheter Ablation Using a Novel Navigation and Imaging System) is: NOT_YET_RECRUITING.

When did Catheter Ablation Using a Novel Navigation and Imaging System start?

Catheter Ablation Using a Novel Navigation and Imaging System started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑